Frédéric Courtier

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation

Damien Luque Paz, Rébecca Jouanneau‐Courville, Jérémie Riou et al. · Blood Advances · 2020 · 70 citations · Full text

Medicine, Hematology, Molecular Genetics +16

Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms

Geoffroy Venton, Frédéric Courtier, Aude Charbonnier et al. · American Journal of Hematology · 2017 · 69 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates

Francis Tsombeng Foguim, Hervé Bogreau, Mathieu Gendrot et al. · Malaria Journal · 2020 · 35 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Targeted molecular characterization shows differences between primary and secondary myelofibrosis

Frédéric Courtier, Sèverine Garnier, Nadine Carbuccia et al. · Genes Chromosomes and Cancer · 2019 · 25 citations

Medicine, Hematology, Molecular Biology +12

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study

Aude Collignon, Camille Montersino, Frédéric Courtier et al. · Blood Cancer Journal · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16